Business Context and Reporting Period
Company: Centene Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: March 10, 2026
Context: The filing discloses a scheduled presentation at the Barclays 28th Annual Global Healthcare Conference and a notice of partial debt redemption.
Key Financial Metrics and Capital Structure
Debt and Liquidity:
- Debt Redemption: The Company issued a notice to redeem $1,000,000,000 aggregate principal amount of its 4.25% Notes due December 15, 2027.
- Redemption Date: March 25, 2026.
- Remaining Debt: Approximately $1,186,664,000 of the 2027 Notes will remain outstanding following the redemption.
- Redemption Price: 100% of principal plus accrued and unpaid interest to, but excluding, the redemption date.
Financial Guidance (2026 Full Year):
- GAAP Diluted EPS: Greater than $1.98.
- Adjusted Diluted EPS (Non-GAAP): Greater than $3.00.
Other Metrics: The filing text does not provide specific values for revenue, profit, cash flow, margins, or total liquidity for the current period.
Material Changes and Events
Debt Reduction: The Company is reducing its outstanding debt load by approximately $1 billion through the partial redemption of the 2027 Notes. This action reduces future interest obligations and alters the capital structure.
Guidance Reaffirmation: Management expects to reaffirm previously issued 2026 full-year earnings guidance during the conference presentation.
Outlook, Risks, and Management Commentary
Management Commentary:
- Management utilizes Non-GAAP measures (excluding amortization of acquired intangible assets and acquisition/divestiture expenses) to evaluate core business performance and determine employee incentives.
- A reconciliation of GAAP to Adjusted EPS was previously filed on February 6, 2026.
Risks and Contingencies:
- Regulatory and Political: Risks include changes in U.S. presidential administrations, Congress, federal/state laws, and funding for government-sponsored healthcare programs (Medicaid, Medicare, ACA).
- Operational: Fluctuations in medical costs, provider behaviors, inflation, and the ability to maintain CMS Star ratings.
- Market and Competitive: Competition for providers and contracts, rate cuts by government payors, and contract reprocurements.
- Financial: Interest rate volatility, credit rating downgrades, and investment portfolio losses.
- Legal and Compliance: Regulatory audits, investigations, cyber-attacks, and data security incidents.
Investor Verification Checklist
- Verify the execution of the $1 billion debt redemption on March 25, 2026, and confirm the remaining principal balance of the 2027 Notes.
- Review the Barclays conference presentation (March 10, 2026) for any updates or changes to the reaffirmed 2026 EPS guidance.
- Examine the February 6, 2026 press release (Exhibit 99.1) for the detailed reconciliation between GAAP and Adjusted EPS.
- Monitor regulatory developments regarding ACA funding, enhanced advance premium tax credits, and state/federal healthcare program terms.
- Assess the impact of the debt reduction on the Company's interest expense and liquidity position in upcoming quarterly reports.